Dirui Industrial Co.,Ltd. (300396.SZ)
CNY 13.0
(1.17%)
CNY 13.0
(1.17%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 572.93 Million CNY | 52.42% |
| 2022 | 375.9 Million CNY | 58.41% |
| 2021 | 237.3 Million CNY | 8.64% |
| 2020 | 218.42 Million CNY | -0.52% |
| 2019 | 219.56 Million CNY | -13.94% |
| 2018 | 255.14 Million CNY | 37.43% |
| 2017 | 185.64 Million CNY | 18.84% |
| 2016 | 156.2 Million CNY | 16.84% |
| 2015 | 133.69 Million CNY | 4.63% |
| 2014 | 127.77 Million CNY | -21.72% |
| 2013 | 163.23 Million CNY | 13.03% |
| 2012 | 144.41 Million CNY | 20.08% |
| 2011 | 120.26 Million CNY | 60.35% |
| 2010 | 74.99 Million CNY | 60.96% |
| 2009 | 46.59 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 446.98 Million CNY | -21.98% |
| 2024 Q3 | 492.71 Million CNY | -5.93% |
| 2024 Q2 | 523.76 Million CNY | 17.18% |
| 2023 Q4 | 572.93 Million CNY | 10.75% |
| 2023 Q3 | 517.34 Million CNY | 15.88% |
| 2023 FY | 572.93 Million CNY | 52.42% |
| 2023 Q1 | 429.39 Million CNY | 14.23% |
| 2023 Q2 | 446.43 Million CNY | 3.97% |
| 2022 FY | 375.9 Million CNY | 58.41% |
| 2022 Q1 | 249.08 Million CNY | 4.97% |
| 2022 Q4 | 375.9 Million CNY | -3.4% |
| 2022 Q3 | 389.12 Million CNY | 26.81% |
| 2022 Q2 | 306.86 Million CNY | 23.19% |
| 2021 FY | 237.3 Million CNY | 8.64% |
| 2021 Q1 | 213.65 Million CNY | -2.18% |
| 2021 Q2 | 238.85 Million CNY | 11.8% |
| 2021 Q3 | 255.87 Million CNY | 7.13% |
| 2021 Q4 | 237.3 Million CNY | -7.26% |
| 2020 Q2 | 280.06 Million CNY | 12.37% |
| 2020 Q3 | 244.81 Million CNY | -12.58% |
| 2020 FY | 218.42 Million CNY | -0.52% |
| 2020 Q1 | 249.23 Million CNY | 13.51% |
| 2020 Q4 | 218.42 Million CNY | -10.78% |
| 2019 FY | 219.56 Million CNY | -13.94% |
| 2019 Q4 | 219.56 Million CNY | -7.51% |
| 2019 Q3 | 237.39 Million CNY | 4.61% |
| 2019 Q2 | 226.92 Million CNY | -3.66% |
| 2019 Q1 | 235.56 Million CNY | -7.67% |
| 2018 Q1 | 197.35 Million CNY | 6.31% |
| 2018 FY | 255.14 Million CNY | 37.43% |
| 2018 Q4 | 255.14 Million CNY | -6.57% |
| 2018 Q3 | 273.09 Million CNY | 33.81% |
| 2018 Q2 | 204.09 Million CNY | 3.42% |
| 2017 Q3 | 178.19 Million CNY | 10.7% |
| 2017 Q4 | 185.64 Million CNY | 4.18% |
| 2017 FY | 185.64 Million CNY | 18.84% |
| 2017 Q1 | 168.59 Million CNY | 7.93% |
| 2017 Q2 | 160.97 Million CNY | -4.52% |
| 2016 Q1 | 144.75 Million CNY | 8.27% |
| 2016 FY | 156.2 Million CNY | 16.84% |
| 2016 Q4 | 156.2 Million CNY | -4.83% |
| 2016 Q3 | 164.13 Million CNY | 8.0% |
| 2016 Q2 | 151.97 Million CNY | 4.98% |
| 2015 Q4 | 133.69 Million CNY | -3.64% |
| 2015 Q2 | 113.86 Million CNY | -6.74% |
| 2015 Q1 | 122.09 Million CNY | -4.45% |
| 2015 FY | 133.69 Million CNY | 4.63% |
| 2015 Q3 | 138.74 Million CNY | 21.85% |
| 2014 Q2 | 178.98 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 FY | 127.77 Million CNY | -21.72% |
| 2014 Q4 | 127.77 Million CNY | -18.5% |
| 2014 Q3 | 156.77 Million CNY | -12.41% |
| 2013 FY | 163.23 Million CNY | 13.03% |
| 2013 Q4 | 163.23 Million CNY | 0.0% |
| 2012 FY | 144.41 Million CNY | 20.08% |
| 2011 FY | 120.26 Million CNY | 60.35% |
| 2010 FY | 74.99 Million CNY | 60.96% |
| 2009 FY | 46.59 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 1.5 Billion CNY | 62.031% |
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -2348.686% |
| Beijing Strong Biotechnologies, Inc. | 229.74 Million CNY | -149.379% |
| Medicalsystem Biotechnology Co., Ltd. | 259.01 Million CNY | -121.202% |
| Maccura Biotechnology Co.Ltd | 907.48 Million CNY | 36.866% |
| Guangzhou Wondfo Biotech Co.,Ltd | 351.4 Million CNY | -63.043% |
| Guangdong Hybribio Biotech Co.,Ltd. | 99.55 Million CNY | -475.48% |
| BGI Genomics Co., Ltd. | 602.18 Million CNY | 4.857% |
| Amoy Diagnostics Co., Ltd. | 28.78 Million CNY | -1890.559% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | -55.812% |